The rejection of Disc Medicines experimental compound for a rare and devastating disorder by the FDA is the latest example of the growing uncertainty at the nation’s top drug regulator https://t.co/6vR7cyr3WO - Buzzberg

The rejection of Disc Medicines experimental compound for a rare and devastating disorder by the FDA is the latest example of the growing uncertainty at the nation’s top drug regulator https://t.co/6vR7cyr3WO

Original source ↗ | February 13, 2026 at 23:13 UTC | Twitter - @business

Sentiment BEARISH

The FDA'

Tickers

DISC SHORT

Views 11,357

Retweets 3

Likes 9

Replies 1

Quotes 2

Bookmarks 3

Trade Ideas

Ticker	Direction	Speaker	Thesis	Time
DISC	SHORT	@business	The FDA'	—